Amundi’s Protolabs PRLB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.05M Sell
12,941
-1,141
-8% -$80.3K ﹤0.01% 1350
2026
Q1
$803K Buy
14,082
+2,031
+17% +$118K ﹤0.01% 1363
2025
Q4
$610K Buy
12,051
+2,753
+30% +$141K ﹤0.01% 1408
2025
Q3
$471K Hold
9,298
﹤0.01% 1350
2025
Q2
$379K Sell
9,298
-729
-7% -$27.2K ﹤0.01% 1446
2025
Q1
$334K Sell
10,027
-16
-0.2% -$631 ﹤0.01% 1580
2024
Q4
$378K Sell
10,043
-490
-5% -$17.6K ﹤0.01% 1621
2024
Q3
$297K Sell
10,533
-1,436
-12% -$43.8K ﹤0.01% 1552
2024
Q2
$367K Sell
11,969
-5,368
-31% -$170K ﹤0.01% 1416
2024
Q1
$538K Buy
17,337
+1,200
+7% +$43.3K ﹤0.01% 1407
2023
Q4
$583K Sell
16,137
-4,643
-22% -$150K ﹤0.01% 1411
2023
Q3
$532K Buy
20,780
+6,364
+44% +$192K ﹤0.01% 1404
2023
Q2
$510K Buy
14,416
+6,367
+79% +$203K ﹤0.01% 1382
2023
Q1
$249K Buy
8,049
+3,690
+85% +$114K ﹤0.01% 1511
2022
Q4
$118K Hold
4,359
﹤0.01% 1582
2022
Q3
$166K Buy
+4,359
New +$189K ﹤0.01% 1478

Other funds holding PRLB

Amundi's PRLB Position: Q2 2026 in Review

Amundi reduced its Protolabs (PRLB) stake by 8.1% in Q2 2026, selling an estimated $80.3K and leaving 12,941 shares worth $1.05M. The position accounts for ﹤0.01% of the portfolio, ranked #1350.

Amundi first reported a position in PRLB in Q3 2022 and has held it in 16 quarters since. 278 funds tracked by Wall St. Rank hold PRLB as of Q2 2026.

  • Amundi held 12,941 shares of Protolabs worth $1.05M as of Q2 2026.
  • Amundi sold 1,141 Protolabs shares in Q2 2026, an estimated $80.3K.
  • Protolabs made up ﹤0.01% of Amundi's portfolio in Q2 2026, its #1350 holding.
  • Amundi first reported a position in Protolabs in Q3 2022 and has held it in 16 quarters since.
  • 278 funds tracked by Wall St. Rank held Protolabs as of Q2 2026.

Based on Amundi's 13F filing for Q2 2026, filed 11 Aug 2026.